BREAST CANCER Updated guideline recommendations for HER2 testing

被引：11

作者：

Rakha, Emad A. ^{[1
]}

Ellis, Ian O. ^{[1
]}

机构：

[1] Univ Nottingham, City Hosp Nottingham, Sch Med, Div Oncol, Nottingham NG5 1PB, England

来源：

NATURE REVIEWS CLINICAL ONCOLOGY | 2014年 / 11卷 / 01期

关键词：

TRASTUZUMAB; CONCORDANCE;

D O I：

10.1038/nrclinonc.2013.230

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The recently updated HER2 testing guidelines by ASCO and the College of American Pathologists (CAP) are a significant step towards personalized medicine. It is excellent news that such great effort has been put into standardizing biomarker assessment. Undoubtedly, these recommendations will improve the analytical validity of HER2 testing, its clinical utility and the communication among health-care providers.

引用

页码：8 / 9

页数：3

共 10 条

[1]

[Anonymous], 2007, J CLIN ONCOL, DOI DOI 10.1200/JCO.2006.09.2775

[2] American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer [J].

Hammond, M. Elizabeth H. ;

Hayes, Daniel F. ;

Dowsett, Mitch ;

Allred, D. Craig ;

Hagerty, Karen L. ;

Badve, Sunil ;

Fitzgibbons, Patrick L. ;

Francis, Glenn ;

Goldstein, Neil S. ;

Hayes, Malcolm ;

Hicks, David G. ;

Lester, Susan ;

Love, Richard ;

Mangu, Pamela B. ;

McShane, Lisa ;

Miller, Keith ;

Osborne, C. Kent ;

Paik, Soonmyung ;

Perlmutter, Jane ;

Rhodes, Anthony ;

Sasano, Hironobu ;

Schwartz, Jared N. ;

Sweep, Fred C. G. ;

Taube, Sheila ;

Torlakovic, Emina Emilia ;

Valenstein, Paul ;

Viale, Giuseppe ;

Visscher, Daniel ;

Wheeler, Thomas ;

Williams, R. Bruce ;

Wittliff, James L. ;

Wolff, Antonio C. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) :2784-2795

[3] HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity [J].

Hanna, Wedad M. ;

Rueschoff, Josef ;

Bilous, Michael ;

Coudry, Renata A. ;

Dowsett, Mitch ;

Osamura, Robert Y. ;

Penault-Llorca, Frederique ;

van de Vijver, Marc ;

Viale, Giuseppe .

MODERN PATHOLOGY, 2014, 27 (01) :4-18

[4] Concordance of HER2 status assessed on needle core biopsy and surgical specimens of invasive carcinoma of the breast [J].

Lee, Andrew H. S. ;

Key, Heather P. ;

Bell, Jane A. ;

Hodi, Zsolt ;

Ellis, Ian O. .

HISTOPATHOLOGY, 2012, 60 (06) :880-884

[5]

Middleton LP, 2009, ARCH PATHOL LAB MED, V133, P775, DOI 10.1043/1543-2165-133.5.775

[6] HER2 status and benefit from adjuvant trastuzumab in breast cancer [J].

Paik, Soonmyung ;

Kim, Chungyeul ;

Wolmark, Norman .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (13) :1409-1411

[7] Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31 [J].

Perez, Edith A. ;

Romond, Edward H. ;

Suman, Vera J. ;

Jeong, Jong-Hyeon ;

Davidson, Nancy E. ;

Geyer, Charles E., Jr. ;

Martino, Silvana ;

Mamounas, Eleftherios P. ;

Kaufman, Peter A. ;

Wolmark, Norman .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (25) :3366-3373

[8] Prognostic significance of Nottingham histologic grade in invasive breast carcinoma [J].

Rakha, Emad A. ;

El-Sayed, Maysa E. ;

Lee, Andrew H. S. ;

Elston, Christopher W. ;

Grainge, Matthew J. ;

Hodi, Zsolt ;

Blamey, Roger W. ;

Ellis, Ian O. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (19) :3153-3158

[9] HER2 Gene Amplification in Breast Cancer A Rogues' Gallery of Challenging Diagnostic Cases: UKNEQAS Interpretation Guidelines and Research Recommendations [J].

Starczynski, Jane ;

Atkey, Neil ;

Connelly, Yvonne ;

O'Grady, Tony ;

Campbell, Fiona M. ;

di Palma, Silvana ;

Wencyk, Peter ;

Jasani, Bharat ;

Gandy, Michael ;

Bartlett, J. M. S. .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (04) :595-605

[10]

Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI [10.1200/JCO.2013.50.9984, 10.5858/arpa.2013-0953-SA]

← 1 →